Lipoprotein(a) and residual risk during statin therapy: Thresholds guide decisions, but risk is continuous
Mohammed Ammar, MD, MSc, MMSc, Samia Mora, MD, MHS; Lipoprotein(a) and residual risk during statin therapy: Thresholds guide decisions, but risk is continu
Authors
- Samia Mora (ORCID: https://orcid.org/0000-0001-6283-0980)
- Mohammed Ammar (ORCID: https://orcid.org/0000-0003-3710-2214)
Institutions
- Brigham and Women's Hospital (US)
- Toronto General Hospital (CA)
Publication Details
- Journal
- European Journal of Preventive Cardiology
- Published
- 2026-09-30
- DOI
- https://doi.org/10.1093/eurjpc/zwag502
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 0.00